112 related articles for article (PubMed ID: 17120291)
1. Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain.
Di Benedetto B; Hitz C; Hölter SM; Kühn R; Vogt Weisenhorn DM; Wurst W
J Comp Neurol; 2007 Jan; 500(3):542-56. PubMed ID: 17120291
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ERK3/MAPK6 expression by BRAF.
Hoeflich KP; Eby MT; Forrest WF; Gray DC; Tien JY; Stern HM; Murray LJ; Davis DP; Modrusan Z; Seshagiri S
Int J Oncol; 2006 Oct; 29(4):839-49. PubMed ID: 16964379
[TBL] [Abstract][Full Text] [Related]
4. Regulation of NR4A nuclear receptor expression by oncogenic BRAF in melanoma cells.
Smith AG; Lim W; Pearen M; Muscat GE; Sturm RA
Pigment Cell Melanoma Res; 2011 Jun; 24(3):551-63. PubMed ID: 21362156
[TBL] [Abstract][Full Text] [Related]
5. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
6. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf.
Dwivedi Y; Rizavi HS; Conley RR; Pandey GN
Mol Psychiatry; 2006 Jan; 11(1):86-98. PubMed ID: 16172610
[TBL] [Abstract][Full Text] [Related]
7. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
8. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
[TBL] [Abstract][Full Text] [Related]
9. Coordinating ERK/MAPK signalling through scaffolds and inhibitors.
Kolch W
Nat Rev Mol Cell Biol; 2005 Nov; 6(11):827-37. PubMed ID: 16227978
[TBL] [Abstract][Full Text] [Related]
10. Rho family GTPase inhibition reveals opposing effects of mitogen-activated protein kinase kinase/extracellular signal-regulated kinase and Janus kinase/signal transducer and activator of transcription signaling cascades on neuronal survival.
Loucks FA; Le SS; Zimmermann AK; Ryan KR; Barth H; Aktories K; Linseman DA
J Neurochem; 2006 May; 97(4):957-67. PubMed ID: 16686690
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
[TBL] [Abstract][Full Text] [Related]
12. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma.
McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1997 Dec; 26(6):1484-91. PubMed ID: 9397988
[TBL] [Abstract][Full Text] [Related]
14. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
15. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
16. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
17. Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways.
Zhang W; Chen T; Wan T; He L; Li N; Yuan Z; Cao X
Biochem Biophys Res Commun; 2000 Aug; 274(3):872-9. PubMed ID: 10924369
[TBL] [Abstract][Full Text] [Related]
18. Dentate Gyrus Development Requires ERK Activity to Maintain Progenitor Population and MAPK Pathway Feedback Regulation.
Vithayathil J; Pucilowska J; Goodnough LH; Atit RP; Landreth GE
J Neurosci; 2015 Apr; 35(17):6836-48. PubMed ID: 25926459
[TBL] [Abstract][Full Text] [Related]
19. MAPK pathway activation and the origins of pediatric low-grade astrocytomas.
Tatevossian RG; Lawson AR; Forshew T; Hindley GF; Ellison DW; Sheer D
J Cell Physiol; 2010 Mar; 222(3):509-14. PubMed ID: 19937730
[TBL] [Abstract][Full Text] [Related]
20. MAP3Ks as central regulators of cell fate during development.
Craig EA; Stevens MV; Vaillancourt RR; Camenisch TD
Dev Dyn; 2008 Nov; 237(11):3102-14. PubMed ID: 18855897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]